#j.a. townsend

[nursingwriter]

Alzheimer's Disease Howenstine, J.A. (2010) How to heal Alzheimer's disease. Townsend Letter 321: 78-85 This is a peer-reviewed 15-page article by James a. Howenstine, MD, a board-certified specialist in internal medicine, who is convinced that natural therapies are more effective, safer, and less expensive than pharmaceutical drugs for Alzheimer's disease treatment. The report includes a list of the items that can destroy the myelin sheath surrounding neurons, and thus greatly increase the risk of being a victim of Alzheimer's disease in one's lifetime. These items can have an effect on a person's neurology from childhood on. Howenstine argues that Alzheimer's is a disease of advanced civilization, and there are technological advancements in modern-day society that have furthered its prevalence. One of these technologies is electric lighting. According to Howenstine, in parts of rural Africa that do not have electricity, there is nearly no Alzheimer's disease. This is because the people living here have longer daily exposure to melatonin, a powerful antioxidant that neutralizes oxidative toxins. Researchers have also confirmed a direct relationship between exposure to electromagnetic radiation and the development of this disease. Similarly, certain metals, such as aluminum, can directly increase the production of free radicals that can harm the myelin sheath. Howenstine reports that there is a 250% increased risk of having Alzheimer's disease when drinking municipal water that is high in aluminum content for over ten years. Studies have shown that patients with Alzheimer's disease have higher blood levels of aluminum and a characteristic brain lesion, or nerve "tangles" containing very high levels of this metal. Exposure to mercury can have this same affect. The gene primarily believed for causation of this illness is APOE4APOE4, which is found to be carried in about 40% of cases sporadic-type Alzheimer's disease in the elderly. People with one APOE4 gene will develop the disease at a lower age than those who have no APOE4 genes. This article also includes a diet and list of nutrients and supplements as valuable therapies. C. This is an article for individuals who are interested in alternative health causes and treatments. It would be helpful for an alternative doctor to have available for his or her patients, as well as other resources that provide information to individuals who have an interest in alternative healthcare. D. The author is a board-certified physician, who is well-known for his books on alternative medical care. The publication Townsend has been published and carrying articles on alternative medicine since 1983. A. Hunt, L.A., Brown, a.E., & Gilman, I.P. (2010) Drivers with dementia and outcomes of becoming lost while driving. American Journal of Occupational Therapy 64(2): 225-233 B. With the increasing numbers of individuals with Alzheimer's disease, due to the aging population, it will be necessary to consider other issues that will be important to address. Studies that analyze driving and dementia have reported that drivers with early onset Alzheimer's disease may continue to drive for extended periods of time, but their driving needs to be regularly evaluated or monitored. This is especially the case, since the earliest symptoms of the disease are recognized to include loss of recent memory and the inability to recognize familiar environments. In an exploratory study, the authors examined 207 reports of lost drivers with dementia over ten years that were reported by newspapers and media. Seventy Alzheimer's disease drivers were not found, 32 drivers were found dead, and 116 drivers were found alive, 35 of these latter were injured. Becoming lost may have serious consequences. Hunt, Brown and Gilman report that additional research is needed about this issue to more clearly understand the consequences of becoming lost while driving. C. This is a topic that is clearly of interest to healthcare providers of seniors and the elderly. It can also be a subject that would be of interest to anyone who either is a senior or has a family member who is a senior and is driving. D. This is a peer-reviewed article that appeared in a reputable publication. A. Doody, R.S., Paylik, V., Massman, P. et al. Predicting progression of Alzheimer's disease. Alzheimer's Research & Therapy 2:2 B. One of major concerns of both healthcare providers and patients is being able to predict the progression of Alzheimer's disease once the onset has been determined, in order to develop biomarkers. These authors tested a calculated initial progression rate to see whether it could predict performance on cognition, function and behavior over time, as well as survival. They used standardized approaches to assess baseline characteristics and to estimate disease duration, to calculate the initial rate in 597 Alzheimer's disease patients who were followed for up to 15 years. The authors designated slow, intermediate and rapidly progressing groups. The slowest progression group survives longer. Their data provides strong evidence that prediction is possible, which addresses an important clinical need. A simple, calculated progression rate at a patient's initial visit can offer reliable information regarding the progression of the disease over time in relationship to cognition, global performance and daily living activities. C. Anyone who either is a healthcare provider for people with Alzheimer's disease, who already has been diagnosed with the disease or has a family member who has Alzheimer's, would be interested in learning more about the findings noted in this study. D. This article appeared in a reputable journal and is peer reviewed. A. Kondro, W. (2010) Dementia strategy urged. Canadian Medical Association 182(3): 169-170 B. As noted above, there will considerable impacts on society with the changing population demographics and the increasing number of expected Alzheimer's disease patients over the coming decades. Kondro argues that Toronto needs to develop an Apan-Canadian plan to allay the effects of this forthcoming epidemic. The Alzheimer's Society of Canada expects that the number of Canadians living with Alzheimer's disease and other forms of dementia will leap to 1.125 million in 2038 from 500,000 in 2008. A projected 257,800 new cases will be diagnosed in 2038, as compared with 103,700 in 2008. This study also estimates that the economic burden of dementia will increase to $153 billion in 2038 from $15 billion in 2008. The report includes five action items: 1) Accelerated investment in all areas of dementia research, such as biomedical, clinical, quality of life, health services and knowledge translation; 2) Clear recognition of the important role played by informal caregivers by providing information and education, and the need to support their roles as care partners and provide financial support; 3) Increased recognition of the importance of prevention and early intervention for this disease, for both healthcare professionals and the general public; 4) Greater integration and care of increased use of accepted frameworks or "best practices" in chronic disease prevention and management, community support and community care coordination; and 5) strengthening Canada's dementia workforce by in such ways as increasing availability of individuals with specialized knowledge of dementia; improving the diagnostic and treatment capabilities of all frontline professionals; making the best use of general and specialized resources through interprofessional collaboration; and leveraging the capabilities of the voluntary sector through investment and training. C. This is a topic that should be of interest to a very wide population including healthcare providers, healthcare administrators, city, state and federal governments, private and public organizations serving seniors and the elderly and the general public. It will be critical that such plans are devised. D. The Alzheimer Society of Canada sponsored this study. A. Ajamian, P.C. (2010) Keep Alzheimer's in mind; if optometrists could identify early Alzheimer's disease in just 1% of their patients, 500,000 people could be helped. Review of Optometry 147(2): 105-107 B. The more healthcare providers who can alert patients to get further medical advice about the possibility of Alzheimer's disease, the better the care of their patients. According to Clement Trempe, M.D., professor of optometry at the New England College of Optometry and head scientist with the Center for Healthy Aging at the New England Eye Institute, optometrists can perform their usual comprehensive eye exam with readily available equipment to detect the ocular signs of Alzheimer's disease early on in the disease process, Trempe says early signs, or biomarkers, can be easily overlooked because the pathological findings associated with Alzheimer's disease are similar to, and overlap with, the findings associated with common age-related eye diseases. These biomarkers include cortical cataract, retinal nerve fiber layer thinning and drusen. For example, Amyloid beta deposits are seen in the cortex of the lens in patients with Alzheimer's disease, which are the same type of proteins that are a hallmark of Alzheimer's when found in the brain. This distortion can be measured highly accurately using the same instruments employed for corneal refractive surgery C. This is important information for vision care specialists as well as the general public. Just as eye-care specialists now perform tests for glaucoma and macular degeneration, they can add this examination for Alzheimer's disease and refer the patient to the proper medical care. D. This paper was done in an informal Q. And a fashion. It would have had more weight if it had included better technical information and studies. A. Harvard Women's Health Watch (2010) Preserving and improving memory as we age. Feb 1: NA B. This is an article that is written directly to consumers who are over the age of 50 and are starting to notice changes in the ability to remember things. It addresses the fact that this wrongly causes fear in some people that they are prone toward Alzheimer's disease. Studies have shown that cognitive decline and the risk of dementia can be maintained with general health habits, such as staying physically active, getting enough sleep, not smoking, having good social connections, limiting alcohol to one drink a day, and eating a balanced diet low in saturated and trans fats. The article provides a number of different ways that people can improve their cognitive abilities, such as blocking: When someone is asked a question and the cannot immediately respond -- the answer is on the tip of his/her tongue -- this is the most familiar example of blocking, the temporary inability to retrieve a memory. Blocking does not occur because someone is not paying attention or because the memory has faded from the brain. In most cases, it is blocked by another, similar memory. For example, parents call their older son by their younger son's name. Memory blocks become more common with age and account for much of the trouble older people have in remembering names. The good news is that about half of the blocked memories can be retrieved within a minute. C. This is an article that would be of interest to the general public, especially those who are over 50 or who have a family member who is this age. It would be helpful for healthcare providers to keep on hand for their patients. D. Harvard Women's Health Watch is a monthly newsletter to keep women informed about the health issues. A. Bruce, L.A. (2010) Drugs for Alzheimer's Disease. MedSurg Nursing 19(1): 51-54 B. Drug therapy for Alzheimer's disease is presently focused on slowing the progression of the disease and managing the symptoms of the cognitive decline. In this report, Bruce covers the two classes of drugs currently approved by the Food and Drug Administration for treatment of the disease: the cholinesterase inhibitors (ChEls) and the single N-methyl-D-aspatate (NMDA) receptor antagonist, the drug memantine. The concern by the author is that patients with dementia may not be able to adhere to treatment plans and report adverse effects. This can create a burden on caregivers, because approximately 70% of persons with Alzheimer's disease live at home with a caregiver who is a family member or friend. Of patients still living in a home setting, 73% currently require assistance with managing and taking their medications. Ongoing research in the pharmacologic treatment of Alzheimer's disease centers on drug delivery systems can improve adherence and minimize adverse effects. In addition, the nurse's role in drug therapy this illness is an important element. Drug efficacy is improved when the drug is taken on a regular and consistent basis. Treatment adherence and reporting of adverse effects can have a positive impact on the patient's condition as well as the quality of life. Teaching the purpose of drug therapy, helping the patient and caregiver choose the easiest drug delivery system for the individual, investigating possible drug-to-drug interactions, and managing adverse effects can relieve some of the burden of the disease's management. C. The information in this report would be helpful for family members and caregivers. However, presently it is not written in layman's terms, but rather for healthcare providers. This population is important, as well, but an additional report should be written for the general public. D. This is a peer-reviewed article in a reputable publication. A. Mayo Clinic. "Alzheimer's Disease" Retrieved April 27, 2010. http://www.mayoclinic.com/health/alzheimers-disease/DS00161 B. It is important for the general public as well as healthcare providers to know that there is a wealth of information that is available online about Alzheimer's disease as well as other illnesses. Of course, some sites are more reputable and have better information than others. The Mayo Clinic normally has excellent information on different medical topics, and the subject of Alzheimer's disease is no different. The web site provides a thorough coverage of the disease form symptoms to treatment, recent news and research studies of interest, a newsletter for caregivers and a slide show on how the brain functions. It also covers the differences between dementia and Alzheimer's disease, which is important information for all people to have. Most people confuse Alzheimer's disease with other dementia concerns. C. Information on this site is of interest for anyone who wants a general background on Alzheimer's disease, as well as those afflicted with the illness and their caregivers and family members. It also provides a foundation for anyone in the healthcare field, although not going into much depth or technical information. D. The Mayo Clinic is a well-known healthcare organization. References Ajamian, P.C. (2010) Keep Alzheimer's in mind; if optometrists could identify early Alzheimer's disease in just 1% of their patients, 500,000 people could be helped. Review of Optometry 147(2): 105-107 Bruce, L.A. (2010) Drugs for Alzheimer's Disease. MedSurg Nursing 19(1): 51-54 Doody, R.S., Paylik, V., Massman, P. et al. Predicting progression of Alzheimer's disease. Alzheimer's Research & Therapy 2:2 Harvard Women's Health Watch (2010) Preserving and improving memory as we age. Feb 1: NA Howenstine, J.A. (2010) How to heal Alzheimer's disease. Townsend Letter 321: 78-85 Hunt, L.A., Brown, a.E., & Gilman, I.P. (2010) Drivers with dementia and outcomes of becoming lost while driving. American Journal of Occupational Therapy 64(2): 225-233 Kondro, W. (2010) Dementia strategy urged. Canadian Medical Association 182(3): 169-170 Mayo Clinic. "Alzheimer's Disease" Retrieved April 27, 2010 https://www.paperdue.com/customer/paper/alzheimer-disease-howenstine-ja-2010-2355#:~:text=Logout-,AlzheimersDiseaseHowenstineJA2010,-Length8pages Read the full article

[davidosu87]

Another Featured Review on Journey with a Cinephile: A Horror Movie Podcast back from November as part of Italian Horror Month. This is an interesting movie that takes religion and uses space as a basis for it. Not a great movie overall, but one that I did enjoy. Have you heard of this one? 

[jackoshadows]

I guess this is what a billion dollar budget gets...

Spy Report: Incredible details from Amazon’s Lord of the Rings! Characters, Sexless Nudity & Halflings too?

Men, Elves and Dwarves have their own sequestered production units for the different Free Peoples [this intriguing bit rather suggests the narrative might be constructed across wide time jumps or told from pockets of different historical viewpoints, perhaps even an anthology approach rotating characters from the various Free Peoples all reacting to the same thing, or just not cooperating with each other in Season 1: but over what timelines we still do not know].

Scripts are only digitally shared among actors and crew under draconian control mechanisms to track any persons who could access them

There is a fake production team shooting decoy footage on fake sets unrelated to the real Production – [thus making some “reports of location sightings” false leads by tricksy hobbitses and we must admit this is very clever indeed! Peter Jackson never used decoys!]

Main unit wrapped shooting in April 2021; while many actors are back in the U.K. or are now on other productions

J.A. Bayona’s episodes are a standalone entry point to the series [like a feature film]

There are more incredible directors and big stars yet to be announced

They are aiming for a mid-2022 release [that is only one short year away and must mean the pressure on Post Production must be remarkable

Some Halflings are dark skin precursors to Shire-hobbits quite possibly “one of three somewhat different breeds” maybe Harfoots; [described by Tolkien in the Prologue to LOTR ‘Concerning Hobbits’ pg. 12: “they were browner of skin,” and also “they moved westward early,” alluding to a time in their Wandering Days, or perhaps earlier when they kept no records of their journeys over the Misty Mountains westward (which may explain a little of why any early antecedents of pre-Shire migration hobbits would appear here in the Second Age instead of Third Age narrative)]

Sir Lenny Henry portrays one such early halfling [Harfoot]

Celebrimbor the ringmaker has been recast

Tom Budge was in that role [this feels like a twenty year-old analogy to the original recasting of Stuart Townsend replaced by Viggo Mortensen in the LOTR Trilogy]

Certain creatures are referred to as Ice Trolls because they can’t be called Cave Trolls (Warner Bros. licensing restriction)

Nudity is sparse and not sexualized— contrary to earlier concerns: but rather this artistic choice represents very dark thematic material suggestive of concentration camp-type visuals of victims, a harrowing portrayal of the corruption of the Elves by dark powers to ultimately become Orcs [if this plays out fully it will may well be one of the most ambitious things undertaken by this production and perhaps by anyone attempting to adapt Tolkien]

Elves will have short/ shorter hairstyles [cue the Twitter threads, both pro and con, and the voting polls, and endless constellations of lovely fan art, so please bring it fans; I’m here for it]

Sauron/Annatar will not be revealed in Season One [going with the oldest axiom of show business “Always leave them wanting more.”

[goldfishbymatisse]

library assignment.

artists.

Koons, J., Sylvester, D. and Rosenblum, R. (2001). Jeff Koons : easyfun-ethereal. New York ; London: Harry N. Abrams.

‌Isaak, J.A. (2000). QR code for Feminism and Contemporary Art Title. London: Routledge.‌

Waldman, D., Holzer, J. and R, S. (1997). Jenny Holzer. New York: Solomon R. Guggenheim Museum.

techniques.

Ackland-Snow, N., Brett, N. and Williams, S. (1997). Fly. New York: Watson-Guptill Publications.

L Weiss (2006). Discover beading. Waukesha, Wis.: Kalmbach Books.

‌100 Embroidery stitches. (1968). Glasgow: Coats.‌

further exploration.

Gillian, L. (2003). Kitsch Deluxe. London: Octopus Publishing Group Ltd.

Merck, M., Townsend, C. and Emin, T. (2002). The art of Tracey Emin. New York, N.Y.: Thames & Hudson.

Tomáš Kulka and Penn State University Press (2018). Kitsch and art. University Park: Pennsylvania State University Press, Druk.‌‌

Dascal, M. and Hanliang Zhang (2007). Traditions of controversy. Amsterdam: John Benjamins.

‌